GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

CHICAGO -- Use of GLP-1 receptor agonists in patients with four solid tumor types was significantly associated with lower rates of progression to metastatic disease over a 5-year period, a propensity…